Trial
NCT01960387
Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Clofarabine
Why stopped
lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-02